Ancora Biotech

Developer of Immunotherapeutics for B cell cancers, metabolic diseases, and chronic hepatitis B infections

placePalo Alto, California, United States calendar_todayFounded 2021 groups12 employees language ancorabiotech.com

Registered entities

Investor mix

2 investors on record; lead investors include Lightspeed Venture Partners.

Investor typeCountShare
Venture capital2100%
Coming soon